1,263
Views
0
CrossRef citations to date
0
Altmetric
Chronic Kidney Disease and Progression

The association between peripheral eosinophil count and chronic kidney disease: evidence from NHANES 1999–2018

, , , , , & show all
Article: 2319324 | Received 07 Aug 2023, Accepted 09 Feb 2024, Published online: 23 Feb 2024

References

  • Liyanage T, Toyama T, Hockham C, et al. Prevalence of chronic kidney disease in Asia: a systematic review and analysis. BMJ Glob Health. 2022;7(1):1. doi: 10.1136/bmjgh-2021-007525.
  • GBD Chronic Kidney Disease Collaboration. Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the global burden of disease study 2017. Lancet. 2020;395(10225):709–11. doi: 10.1016/S0140-6736(20)30045-3.
  • Kadatane SP, Satariano M, Massey M, et al. The role of inflammation in CKD. Cells. 2023;12(12):1581. doi: 10.3390/cells12121581.
  • Akuthota P, Wang HB, Spencer LA, et al. Immunoregulatory roles of eosinophils: a new look at a familiar cell. Clin Exp Allergy. 2008;38(8):1254–1263. doi: 10.1111/j.1365-2222.2008.03037.x.
  • Syeda MZ, Hong T, Zhang C, et al. Eosinophils: a friend or foe in human health and diseases. Kidney Dis. 2022;9(1):26–38. doi: 10.1159/000528156.
  • Hattori K, Sakaguchi Y, Oka T, et al. Interstitial eosinophilic aggregates and kidney outcome in patients with CKD. Clin J Am Soc Nephrol. 2023;18(12):1563–1572. doi: 10.2215/CJN.0000000000000277.
  • Kielar D, Jones AM, Wang X, et al. Association between elevated blood eosinophils and chronic kidney disease progression: analyses of a large United States electronic health records database. Int J Nephrol Renovasc Dis. 2023;16:269–280. doi: 10.2147/IJNRD.S431375.
  • Pongdee T, Manemann SM, Decker PA, et al. Rethinking blood eosinophil counts: epidemiology, associated chronic diseases, and increased risks of cardiovascular disease. J Allergy Clin Immunol Glob. 2022;1(4):233–240. doi: 10.1016/j.jacig.2022.09.001.
  • Yen CH, Wu IW, Lee CC, et al. The prognostic value of peripheral total and differential leukocyte count in renal progression: a community-based study. PLOS One. 2021;16(10):e0258210. doi: 10.1371/journal.pone.0258210.
  • Kang DH, Lee Y, Kleine CE, et al. Eosinophil count and mortality risk in incident hemodialysis patients. Nephrol Dial Transplant. 2020;35(6):1032–1042. doi: 10.1093/ndt/gfz296.
  • Yang J, Fan J, Fan L, et al. Higher eosinophils predict death-censored technique failure in peritoneal dialysis patients. Int Arch Allergy Immunol. 2020;181(10):765–773. doi: 10.1159/000509085.
  • Tariq A, Okamato K, Tariq A, et al. Eosinophilia and risk of incident end stage kidney disease. BMC Nephrol. 2020;21(1):14. doi: 10.1186/s12882-020-1685-3.
  • Hildebrand S, Corbett R, Duncan N, et al. Increased prevalence of eosinophilia in a hemodialysis population: longitudinal and case control studies. Hemodial Int. 2016;20(3):414–420. doi: 10.1111/hdi.12395.
  • Nakhjavani M, Aghajani Nargesi A, Salabati M, et al. Changes in leukocyte subpopulations with decline in glomerular filtration rate in patients with type 2 diabetes. Acta Med Iran. 2015l;53(7):425–431.
  • Ishii R, Fujita S, Kizawa S, et al. Association between ­absolute blood eosinophil count and CKD stages among cardiac patients. Heart Vessels. 2016;31(2):198–205. doi: 10.1007/s00380-014-0590-8.
  • Agarwal R, Light RP. Patterns and prognostic value of total and differential leukocyte count in chronic kidney disease. Clin J Am Soc Nephrol. 2011;6(6):1393–1399. doi: 10.2215/CJN.10521110.
  • Diskin CJ, Stokes TJ, Dansby LM, et al. The prevalence and meaning of eosinophilia in renal diseases on a ­nephrology consultation service. Nephrol Dial Transplant. 2011;26(8):2549–2558. doi: 10.1093/ndt/gfq745.
  • Fukui M, Tanaka M, Hamaguchi M, et al. Eosinophil count is positively correlated with albumin excretion rate in men with type 2 diabetes. Clin J Am Soc Nephrol. 2009;4(11):1761–1765. doi: 10.2215/CJN.03330509.
  • Colas L, Bui L, Kerleau C, et al. Time-dependent blood eosinophilia count increases the risk of kidney allograft rejection. EBioMedicine. 2021;73:103645. doi: 10.1016/j.ebiom.2021.103645.
  • Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604–612. doi: 10.7326/0003-4819-150-9-200905050-00006.
  • Hartl S, Breyer MK, Burghuber OC, et al. Blood eosinophil count in the general population: typical values and potential confounders. Eur Respir J. 2020;55(5):1901874. doi: 10.1183/13993003.01874-2019.
  • Hallan S, de Mutsert R, Carlsen S, et al. Obesity, smoking, and physical inactivity as risk factors for CKD: are men more vulnerable? Am J Kidney Dis. 2006;47(3):396–405. doi: 10.1053/j.ajkd.2005.11.027.
  • Zhu L, Su T, Xu M, et al. Eosinophil inversely associates with type 2 diabetes and insulin resistance in Chinese adults. PLOS One. 2013;8(7):e67613. doi: 10.1371/journal.pone.0067613.
  • Malinovschi A, Fonseca JA, Jacinto T, et al. Exhaled nitric oxide levels and blood eosinophil counts independently associate with wheeze and asthma events in national health and nutrition examination survey subjects. J Allergy Clin Immunol. 2013;132(4):821–827.e1-5. doi: 10.1016/j.jaci.2013.06.007.
  • Liu DW, Zhen XG, Liang Y, et al. Persistent asthma increases the risk of chronic kidney disease: a retrospective cohort study of 2354 patients with asthma. Chin Med J . 2013;126(21):4093–4099. doi: 10.3760/cma.j.issn.0366-6999.20131431.
  • Matsumura T, Taketa K, Motoshima H, et al. Association between circulating leukocyte subtype counts and ­carotid intima-media thickness in japanese subjects with type 2 diabetes. Cardiovasc Diabetol. 2013;12(1):177. doi: 10.1186/1475-2840-12-177.
  • Dai DF, Sasaki K, Lin MY, et al. Interstitial eosinophilic aggregates in diabetic nephropathy: allergy or not? Nephrol Dial Transplant. 2015;30(8):1370–1376. doi: 10.1093/ndt/gfv067.
  • Raghavan R, Shawar S. Mechanisms of drug-induced interstitial nephritis. Adv Chronic Kidney Dis. 2017;24(2):64–71. doi: 10.1053/j.ackd.2016.11.004.
  • Colon S, Luan H, Liu Y, et al. Peroxidasin and eosinophil peroxidase, but not myeloperoxidase, contribute to ­renal fibrosis in the murine unilateral ureteral obstruction model. Am J Physiol Renal Physiol. 2019;316(2):F360–F371. doi: 10.1152/ajprenal.00291.2018.
  • Wu WY, Zhou XJ, Sun PP, et al. Interstitial eosinophilic infiltration in diabetic nephropathy is indicative of poor prognosis, with no therapy benefit from steroid. J Diabetes. 2020;12(12):881–894. doi: 10.1111/1753-0407.13077.
  • Pang L, Ding Z, Chai H, et al. The causal relationship between immune cells and different kidney diseases: a mendelian randomization study. Open Med. 2023;18(1):20230877. doi: 10.1515/med-2023-0877.
  • Wheelock KM, Saulnier PJ, Tanamas SK, et al. White blood cell fractions correlate with lesions of diabetic kidney disease and predict loss of kidney function in type 2 diabetes. Nephrol Dial Transplant. 2018;33(6):1001–1009. doi: 10.1093/ndt/gfx231.
  • Whaley-Connell AT, Sowers JR, Stevens LA, et al. CKD in the United States: kidney early evaluation program (KEEP) and national health and nutrition examination survey (NHANES) 1999-2004. Am J Kidney Dis. 2008;51(4 Suppl 2):S13–S20. doi: 10.1053/j.ajkd.2007.12.016.